Viva Pharmaceutical Inc.

Canada

Retour au propriétaire

1-22 de 22 pour Viva Pharmaceutical Inc. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 16
        Marque 6
Juridiction
        Canada 9
        International 7
        États-Unis 6
Date
2025 août 1
2025 (AACJ) 1
2023 1
Avant 2020 16
Classe IPC
A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat 6
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes 4
A61J 3/07 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de capsules ou de petits conteneurs similaires à absorber par voie buccale 3
A61K 36/076 - Poria 3
A61K 36/315 - Isatis, p. ex. indigo 3
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 6
29 - Viande, produits laitiers et aliments préparés ou conservés 2
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 1
02 - Couleurs, vernis, laques 1
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser. 1
Voir plus
Statut
En Instance 2
Enregistré / En vigueur 20

1.

V VIVA NUTRACEUTICALS

      
Numéro d'application 241550200
Statut En instance
Date de dépôt 2025-08-01
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Dietary and nutritional supplements for general health and well being; dietary and nutritional supplements for animals for general health and well being

2.

VIVA

      
Numéro d'application 229119400
Statut En instance
Date de dépôt 2023-11-06
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Dietary supplements & food for animals.

3.

InsoZia

      
Numéro d'application 176036700
Statut Enregistrée
Date de dépôt 2015-12-18
Date d'enregistrement 2016-11-15
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Herbal supplement for relieving insomnia symptoms; dietary supplement for relieving insomnia symptoms; botanical supplement for relieving insomnia symptoms; nutritional supplement for relieving insomnia symptoms; herbal supplement for relieving anxiety and irritability; dietary supplement for relieving anxiety and irritability; nutritional supplement for relieving anxiety and irritability; botanical supplement for relieving anxiety and irritability; herbal supplement for improving the difficulty falling and staying asleep; dietary supplement for improving the difficulty falling and staying asleep; botanical supplement for improving the difficulty falling and staying asleep; nutritional supplement for improving the difficulty falling and staying asleep; herbal supplement for nourishing the heart and calming the spirit; dietary supplement for nourishing the heart and calming the spirit; botanical supplement for nourishing the heart and calming the spirit; nutritional supplement for nourishing the heart and calming the spirit; herbal supplement for improving sleep pattern; dietary supplement for improving sleep pattern; botanical supplement for improving sleep pattern; nutritional supplement for improving sleep pattern; herbal supplement for improving biological clock; dietary supplement for improving biological clock; botanical supplement for improving biological clock; nutritional supplement for improving biological clock; herbal supplement for improving circadian rhythm; dietary supplement for improving circadian rhythm; botanical supplement for improving circadian rhythm; nutritional supplement for improving circadian rhythm; herbal supplement for improving immune system; dietary supplement for improving immune system; botanical supplement for improving immune system; nutritional supplement for improving immune system; herbal supplement for improving memory; dietary supplement for improving memory; botanical supplement for improving memory; nutritional supplement for improving memory; herbal supplement for alleviating palpitation; dietary supplement for alleviating palpitation; botanical supplement for alleviating palpitation; nutritional supplement for alleviating palpitation;herbal supplement for alleviating fidgetiness; dietary supplement for alleviating fidgetiness; botanical supplement for alleviating fidgetiness; nutritional supplement for alleviating fidgetiness; herbal supplement to improve sleep quality; dietary supplement for improve sleep quality; botanical supplement for improve sleep quality; nutritional supplement for improve sleep quality; herbal supplement for modulating physiological sleep disorders; dietary supplement for modulating physiological sleep disorders; botanical supplement for modulating physiological sleep disorders; nutritional supplement for modulating physiological sleep disorders; herbal supplement for improving the heart, kidney and large intestine meridians; dietary supplement for improving the heart, kidney and large intestine meridians; botanical supplement for improving the heart, kidney and large intestine meridians; nutritional supplement for improving the heart, kidney and large intestine meridians; herbal supplement for treating restlessness; dietary supplement for treating restlessness; botanical supplement for treating restlessness; nutritional supplement for treating restlessness; botanical supplements for general health and well-being; dietary supplements for general health and well-being; herbal supplements for general health and well-being; nutritional supplements for general health and well-being; sleeping pills; sleep-aid pills (1) Insomnia therapy services; sleep disorder clinics

4.

N-acetyl L-cysteine chelates and methods for making and using the same

      
Numéro d'application 14713830
Numéro de brevet 09597308
Statut Délivré - en vigueur
Date de dépôt 2015-05-15
Date de la première publication 2015-09-03
Date d'octroi 2017-03-21
Propriétaire Viva Pharmaceutical, Inc. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Daniels, Rhett Sean

Abrégé

A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to zinc to form a chelate ring. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with zinc. A compound having a chelate formulation with zinc being chelated by an N-acetyl-L-cysteine ligand.

Classes IPC  ?

5.

V VIVA

      
Numéro d'application 173442400
Statut Enregistrée
Date de dépôt 2015-06-25
Date d'enregistrement 2019-07-05
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 02 - Couleurs, vernis, laques
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 09 - Appareils et instruments scientifiques et électriques
  • 16 - Papier, carton et produits en ces matières
  • 29 - Viande, produits laitiers et aliments préparés ou conservés
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries
  • 31 - Produits agricoles; animaux vivants

Produits et services

(1) Chemical, biological and diagnostic reagents for scientific and research use, namely, diagnostic reagents for medical diagnostic use, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical drug precursors, excipients, dispersants, pigments, granulating agents and opacifiers all for use in the manufacture of pharmaceutical drug preparations and substances; skin clarifiers and skin masks; skin cleansing lotions, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; skin emollient preparations, hair care preparations and skin care preparations, namely, anti-inflammatory ointments, corticosteroid ointments and creams, scabicides; full line of pharmaceutical preparations and substances, namely, pharmaceutical preparations and substances for the treatment, alleviation or prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, bipolar disorder, depression, migraines, addiction, attention deficit/hyperactivity disorder, catalepsy, epilepsy/seizures, encephalitis, meningitis, arachnoid cysts, Alzheimer's, Parkinson's, multiple sclerosis, and for enhancing attention, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, and migraines and other forms of headache; analgesics; anaesthetics; anti-inflammatories; antidepressants; broncho-dilators; anti-cancer preparations; medicated lotions for the skin and hair and dermatologicals, namely, deep scalp cleanser, conditioner for hair loss, anti-dandruff compositions, chemical color agent removers for hair, lotions for removing dark spots or sun spots on skin, pore minimizers, wart removal lotions, corn and callus removers, acne therapy and lotions for crow's feet, aromatherapy, reducing scaling, eczema, psoriasis, oily skin, dark wrinkles, cellulite, stretch marks, bug repellents, bug bite treatments, skin cut and burn lotion, skin whitening lotion, blackhead remover, lotions for improving uneven skin tone, cuticle removers, lotion for treating collagen dysfunction, hair growth, for muscle pain relief, sunscreens, anti-wrinkle lotion, anti-aging lotion, make-up remover, skin brightening lotion; decongestants and anti-histamines; muscle relaxants; anti-emetics; immunosuppressive agents; antispasmodic agents, antiepileptic agents; cardiotonics; scabicides; anti-malarials; cough suppressants; cough and cold preparations; expectorants; anti-leukemic agents; anti-arrhythmics; lung surfactants; vasopressors; antitumour agents; antidotes to digitalis poisoning; preparations for treatment of digoxin and digitoxin intoxication; antineoplastic agents; antiprotozoal agents; nondepolarizing skeletal neuromuscular blocking agents; preparations for treatment of gout; xanthine oxidase inhibitors; preparations for cessation of smoking; preparations for treatment of Parkinson's disease; preparations for treatment of hypothyroidism; full line of nutraceutical preparations and substances, namely extracts or isolates from plant, alga, fungus, non-human animal material, bacterium (including spirulina and non-living, e.g. tyndallized bacteria), namely, enzymes, namely digestive enzymes, amylase, nucleases, alpha-galactosidase, beta-glucanase, cellulase, glucoamylase, hemicellulose, invertase, lactase, phytase, xylanase, proteases, bromelain, papain, lipase, pancreatin, serratiopeptidase, nattokinase, lysozyme, vitamins, minerals, amino acids, essential fatty acids, probiotics, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; probiotics, namely, acidophilus, bifidobacterium, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; vitamin compounds, namely, vitamin supplements, vitamins, multi-vitamins, vitamin compounds with minerals, vitamin compounds with iron, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; mineral preparations, namely minerals, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; nutritional, dietary and herbal supplements and herbal preparations, namely, semen platycladi, radix polygalae, indole-3-carbionol, 5-hydroxy-L-tryptophan, echinacea, bilberry, cascara sagrada, celery seed, cranberry, nettle root, uva ursi, dandelion root, devil's claw, feverfew, ginger root, ginkgo biloba, grapeseed, resveratrol, citrus bioflavonoids, green tea, hawthorn, horse chestnut, milk thistle, olive leaf, panax ginseng, saw palmetto, siberian ginseng, silica, St. John's Wort, valerian, lutein, zeaxanthin, cayenne, hawaiian spirulina, swedish bitters, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; fatty supplements namely, flax seed oil and fish derived oils, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; glucosamine, chondroitin, methyl-sulfonyl-methane, whey, creatine, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; herbal products, namely, for treating disorders of the sleep-wake cycle, namely insomnia and sleep disorders, for treating the nervous system and mental health, namely, loss of focus, irregular emotional control, attention, bipolar disorder, depression, anxiety, migraines, addiction, attention deficit/hyperactivity disorder, catalepsy, epilepsy/seizures, encephalitis, arachnoid cysts, Alzheimer's disease, Parkinson's neurological disorders, multiple sclerosis, memory loss, anorexia, and nausea, anti-infectives for pneumonia, cough, respiratory inflammation, allergies, meningitis, and immune system dysfunction, anti-inflammatories, for treating vision, namely age- related macular degeneration, night vision problems, myopia, floaters, and cataracts, for cardiovascular disorders, namely high blood pressure, high cholesterol, cardiovascular disease, stroke, heart attack, high blood sugar, diabetes, coronary heart disease, and anemia, for treating hemorrhoids, for body support, namely, joint pain, osteoporosis, bone density loss, arthritis, obesity, overweight, and growth enhancement, for the digestive system, namely, for stomach ulcers, acidic stomach, stomach pH imbalance, constipation, diarrhea, and heartburn, for detoxification, namely liver toxin remover, carcinogen suppressor and antioxidants, for reproductive system, namely benign prostatic hyperplasia; standardized herbal extracts, namely, semen platycladi, radix polygalae, echinacea, bilberry, cascara sagrada, celery seed, cranberry, nettle root, uva ursi, dandelion root, devil's claw, feverfew, ginger root, ginkgo biloba, grapeseed, green tea, hawthorn, horse chestnut, milk thistle, olive leaf, panax ginseng, saw palmetto, siberian ginseng, silica, St. John's Wort, valerian, lutein, zeaxanthin, cayenne, hawaiian spirulina, swedish bitters, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; nutraceuticals, namely, dietary supplements and herbal products, namely, folic acid, lutein, zeaxanthin, lycopene, acidophilus, bee pollen, beta-carotene, bromelain, choline, flavonoids, grape seed extract, kelp, lecithin, lipoic acid, mushroom extracts, SAM-e, crustacean exoskeleton, soy protein, spirulina, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; amino acid compounds, namely, NAC (n-acetyl cysteine) and L-glutamine, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; sports nutrition products, namely, whey proteins and creatines; antioxidants, namely, vitamins C and E, vitamin A, beta-carotene, selenium and carotenoids, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; cosmeceuticals and tissue healants, namely, medicinal herbal creams, lotions and oils for treatment of skin damage and repair, namely deep scalp cleanser, conditioner for hair loss, anti-dandruff compositions, chemical color agent removers for hair, lotions for removing dark spots or sun spots on skin, pore minimizers, wart removal lotions, corn and callus removers, acne therapy, lotions for crow's feet, aromatherapy, reducing scaling, eczema, psoriasis, oily skin, dark wrinkles, cellulite, stretch marks, bug repellents, bug bite treatments, skin cut and burn lotion, skin whitening lotion, blackhead remover, lotions for improving uneven skin tone, cuticle removers, collagen dysfunction, hair growth, for muscle pain relief; food products, namely, herbs, vegetable greens, dehydrated foods derived from plants namely, vegetable and fruit powder, vegetable protein and greens, natural flavors derived from fruits, dietary fiber; evening primrose oil, salmon oil, whey, creatine, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; nutritional products and natural health products, namely, carotenoids, enzymes, namely, digestive enzymes, amylase, nucleases, alpha-galactosidase, beta-glucanase, cellulase, glucoamylase, hemicellulose, invertase, lactase, phytase, xylanase, proteases, bromelain, papain, lipase, pancreatin, serratiopeptidase, nattokinase, lysozyme, alfalfa leaf, conjugated linoleic acid, apple cider vinegar, fenugreek seed, coenzyme Q10, alpha lipoic acid, pine bark extract, crustacean exoskeleton, garlic, kelp, pectin, policosanol, flaxseed oil, pumpkin seed oil, borage oil, perilla seed oil, salmon oil, evening primrose oil, tuna oil, thyme oil, peppermint oil complex, lecithin, phosphatidyl choline, soya lecithin granules, phosphatidyl serine, bee pollen, bee propolis, royal jelly, soy isoflavones complex, chasteberry, echinacea, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; skin emollient preparations, hair care preparations and skin care preparations, namely, dermatologicals, antibiotic tissue healants, antibacterial ointments, antiinfective ointments and creams, scabicides, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; anti-viral ointments and creams, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; skin cleansing lotions, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; antivirals, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; anti-infectives, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; antibiotics, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; antiseptic skin cleanser and lotions for reducing skin irritation, rash, redness, itching, dryness and inflammation, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; skin moistening lotion; lotion for treating shingles, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; moisturizer; antiseptics, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; ophthalmic and optic agents; probiotics, namely, lactobacillus, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; herbal products, namely, anti-infectives for influenza, hepatits, urinary tract infection, and HSV infection, for growth enhancement for the digestive system, namely for intestinal track microbial balance; cosmeceuticals and tissue healants, namely, medicinal herbal creams, lotions and oils for reducing skin irritation, rash, redness, itching, dryness and inflammation, antiseptic skin cleanser, skin moistening lotion, lotion for treating shingles, antiseptics, none of the foregoing goods being for use in the treatment or prevention of sexually transmitted viral, bacterial or fungal diseases or genital use; herbal products, namely for sexual dysfunction, erectile dysfunction, and premature ejaculation, all of the foregoing goods being for oral administration only; electronic and downloadable publications, namely, product manuals, informational sheets, magazines, journals, newsletters, brochures and books in the pharmaceutical, medical, disease management and health care fields; printed publications, namely, product manuals, informational sheets, magazines, journals, newsletters, brochures and books in the pharmaceutical, medical, disease management and health care fields

6.

N-acetyl L-cysteine chelates and methods for making and using the same

      
Numéro d'application 14142683
Numéro de brevet 09062086
Statut Délivré - en vigueur
Date de dépôt 2013-12-27
Date de la première publication 2015-02-05
Date d'octroi 2015-06-23
Propriétaire Viva Pharmaceutical, Inc. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Daniels, Rhett Sean
  • Gahan, Patricia

Abrégé

A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stifling and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.

Classes IPC  ?

7.

N-ACETYL L-CYSTEINE CHELATES AND METHODS FOR MAKING AND USING THE SAME

      
Numéro d'application US2013053440
Numéro de publication 2014/209412
Statut Délivré - en vigueur
Date de dépôt 2013-08-02
Date de publication 2014-12-31
Propriétaire VIVA PHARMACEUTICAL, INC. (Canada)
Inventeur(s) Xie, Xueju

Abrégé

A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stirring and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.

Classes IPC  ?

  • A01N 37/12 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques contenant le groupe , dans lequel Cn représente un squelette carboné ne comportant pas de cycleLeurs thio-analogues
  • A01N 37/44 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques contenant au moins un groupe carboxylique ou un thio-analogue, ou un de leurs dérivés, et un atome d'azote lié au même squelette carboné par une liaison simple ou double, cet atome d'azote ne faisant pas partie d'un dérivé ou d'un thio-analogue d'un groupe carboxylique, p. ex. acides aminocarboxyliques

8.

PROBIOTIC SOFT GEL COMPOSITIONS

      
Numéro d'application CA2011001218
Numéro de publication 2012/097429
Statut Délivré - en vigueur
Date de dépôt 2011-11-01
Date de publication 2012-07-26
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Jason

Abrégé

This disclosure relates to soft gel capsules. In particular, this disclosure relates to soft gel capsules comprising soft gel capsule comprising an outer shell comprising gelatin; and a filling comprising a probiotic and a desiccant. This disclosure further relates a process for producing a soft gel capsule, said process comprising providing an outer shell composition comprising a gelling agent; providing a filling composition comprising a probiotic and a desiccant; forming a soft gel capsule from the outer shell composition; and introducing the filling composition to the inside of the outer shell composition.

Classes IPC  ?

  • A61K 35/74 - Bactéries
  • A61J 3/07 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de capsules ou de petits conteneurs similaires à absorber par voie buccale
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61P 3/12 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase des électrolytes

9.

AMINOFERR

      
Numéro de série 85463836
Statut Enregistrée
Date de dépôt 2011-11-03
Date d'enregistrement 2013-10-08
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Chelates containing amino acids for use as a dietary and/or nutritional supplement for iron deficiency

10.

CHEWABLE SOFTGEL CAPSULES

      
Numéro d'application CA2010000788
Numéro de publication 2011/014942
Statut Délivré - en vigueur
Date de dépôt 2010-04-27
Date de publication 2011-02-10
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason, Jiang-Chung

Abrégé

A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition and more preferably between about 30% to 47%, at least one plasticizer in an amount selected to render flexible the outer shell composition, at least one starch, and an anti-tacking and softening agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule comprises the at least one starch in a range of about 5% to 30% of the total weight and more preferably about 10% to 20% of the total weight of the shell composition. The chewable softgel capsule is suitable for encapsulating medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.

Classes IPC  ?

  • A23L 1/05 - contenant des agents gélifiants ou épaississants (A23L 1/06 a priorité);;
  • A23P 1/04 - Mise en capsules de particules, p.ex. additifs alimentaires (agents aromatiques A23L 1/22)

11.

PLANT EXTRACT COMPOSITIONS FOR PREVENTION AND TREATMENT OF INFLUENZA

      
Numéro d'application CA2010000304
Numéro de publication 2010/099613
Statut Délivré - en vigueur
Date de dépôt 2010-03-02
Date de publication 2010-09-10
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Jason Jiang-Chung

Abrégé

A composition for affecting one or more of influenza, inflammation, and immune system function, said composition comprising an extract prepared from Radix isatidis and an extract prepared from Flos Lonicerae. In alternative embodiments, the composition further comprises one or more of an extract prepared from Poria cocos(Schw.) Wolf and an extract prepared from Herba houttuyniae. Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.

Classes IPC  ?

  • A61K 36/355 - Lonicera (chèvrefeuille)
  • A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
  • A61K 36/076 - Poria
  • A61K 36/315 - Isatis, p. ex. indigo
  • A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
  • A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
  • A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques

12.

Plant extract compositions for prevention and treatment of influenza

      
Numéro d'application 12716167
Numéro de brevet 09186385
Statut Délivré - en vigueur
Date de dépôt 2010-03-02
Date de la première publication 2010-09-09
Date d'octroi 2015-11-17
Propriétaire Viva Pharmaceutical Inc. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Jason Jiang-Chung

Abrégé

Herba houttuyniae. Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.

Classes IPC  ?

  • A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
  • A61K 36/355 - Lonicera (chèvrefeuille)
  • A61K 36/315 - Isatis, p. ex. indigo
  • A61K 36/076 - Poria
  • A61K 36/185 - Magnoliopsida (dicotylédones)

13.

PLANT EXTRACT COMPOSITIONS FOR AFFECTING SLEEP

      
Numéro d'application CA2009001600
Numéro de publication 2010/060190
Statut Délivré - en vigueur
Date de dépôt 2009-11-03
Date de publication 2010-06-03
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason, Jiang-Chung
  • Gafney, Richard, William

Abrégé

A composition for modulating physiological sleep disorders comprising a therapeutically effective amount of a Platycladus orientalis extract and a pharmaceutically acceptable carrier, and methods for producing said composition The composition may additionally comprise a therapeutically effective amount of at least one of a Polygala spp extract and a Ziziphus jujube extract, or mixtures thereof

Classes IPC  ?

  • A61K 36/14 - Cupressaceae (famille du cyprès), p. ex. genévrier ou cyprès
  • A61K 36/69 - Polygalaceae (famille du polygale)
  • A61K 36/725 - Ziziphus, p. ex. jujube
  • A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
  • A61P 25/20 - HypnotiquesSédatifs
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61K 9/20 - Pilules, pastilles ou comprimés

14.

Plant extract compositions for affecting sleep

      
Numéro d'application 12263868
Numéro de brevet 07968128
Statut Délivré - en vigueur
Date de dépôt 2008-11-03
Date de la première publication 2010-05-06
Date d'octroi 2011-06-28
Propriétaire VIVA Pharmaceutical Inc. (Canada)
Inventeur(s)
  • Xie, Xueji
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason Jiang-Chung
  • Gafney, Richard William

Abrégé

A composition for affecting physiological sleep disorders comprising a therapeutically effective amount of Baiziren extract or any of its derivatives, and a pharmaceutically acceptable carrier. The composition may additionally comprise a therapeutically effective amount of at least one of a Suanzaoren extract and a Yuanzhi extract, or mixtures thereof.

Classes IPC  ?

  • A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes

15.

Chewable softgel capsules

      
Numéro d'application 12543435
Numéro de brevet 07662406
Statut Délivré - en vigueur
Date de dépôt 2009-08-18
Date de la première publication 2010-02-16
Date d'octroi 2010-02-16
Propriétaire Viva Pharmaceutical Inc. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason Jiang-Chung

Abrégé

A chewable softgel capsule configured for encasing orally ingestible articles. The chewable soft capsule is provided with an outer shell composition which comprises at least one gelatin in a range of 20% to 60% of the total weight of the shell composition, at least one plasticizer in an amount selected to render flexible the outer shell composition, an anti-tacking agent in an amount selected to render the outer shell composition non-sticky, and water. In one embodiment the chewable soft capsule further comprises at least one starch in a range of 0.1% to 35% of the total weight of the shell composition. The chewable softgel capsule is suitable for encasing therein medicines, pharmaceutical compositions, nutraceuticals, vitamins, nutritional supplements, and the like.

Classes IPC  ?

  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61K 9/64 - Revêtements organiques contenant des protéines ou leurs dérivés
  • A61K 9/66 - Préparations en capsules, p. ex. de gélatine, de chocolat du type à libération prolongée ou discontinue contenant des émulsions, dispersions ou solutions

16.

ENTERIC COATINGS FOR ORALLY INGESTIBLE COMPOSITIONS

      
Numéro d'application CA2008001650
Numéro de publication 2009/036565
Statut Délivré - en vigueur
Date de dépôt 2008-09-17
Date de publication 2009-03-26
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason Jiang-Chung

Abrégé

A dry suspendible enteric coating composition for suspension in water and then encasing orally ingestible articles. The dry suspendible enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates and alginic acids, a pH-independent water insoluble polymer selected from the group comprising ethylcellulose and ethylcellulose- containg compositions, and a plasticizer selected from the group containing triethyl citrate, glycerin, propylene glycol, triacetin, acetylated monoglycerides, dibutyl sebacate, polyethylene glycols, sorbitals, middle chain triglycerides and combinations thereof. A three-step method for providing a stable outer enteric coating on an ingestable item comprising a first step of encasing the item with a suspension comprising a mixture of at least a sugar and a microcrystalline cellulose, a second step of then encasing the item with a suspension comprising a mixture of a film-forming polymer and a plasticizer, and a third step of finally encasing the item with the enteric coating composition.

Classes IPC  ?

  • A61K 9/52 - Préparations en capsules, p. ex. de gélatine, de chocolat du type à libération prolongée ou discontinue
  • A61J 3/07 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de capsules ou de petits conteneurs similaires à absorber par voie buccale
  • A61K 9/36 - Revêtements organiques contenant des hydrates de carbone ou leurs dérivés
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat

17.

METHODS FOR PRODUCING PURE AMINO ACID CHELATE COMPLEXES, AND USES THEREOF

      
Numéro d'application CA2007001668
Numéro de publication 2008/034238
Statut Délivré - en vigueur
Date de dépôt 2007-09-18
Date de publication 2008-03-27
Propriétaire VIVA PHARMACEUTICALS INC. (Canada)
Inventeur(s)
  • Miroshnychenko, Oleksandr
  • Xie, Xueju
  • Ko, Jason Jiang-Chung

Abrégé

A two-stage method of preparing essentially pure amino acid chelates, wherein the first stage comprises contacting a metal ion from a metal oxide or hydroxide with an amino acid thereby producing a metal hydroxyl amino acetate. The second stage comprises contacting the metal hydroxyl amino acetate from the first stage, with at least one amino-containing compound provided in excess thereby producing a reaction solution containing an amino acid chelate reaction product comprising a metal ion bound to a plurality of amino acid ligands wherein the plurality of amino acid ligands is equal to the coordination number of the metal ion, and then separating the amino acid chelate from the reaction solution. The second stage may include a plurality of steps for sequentially reacting the reaction product with a plurality of amino-containing compounds. The amino acid chelates thus produced can be incorporated into compositions comprising beverages, foodstuffs, nutraceuticals and pharmaceutical adjuvants.

Classes IPC  ?

  • C07C 229/76 - Complexes métalliques d'acides aminocarboxyliques
  • A23L 1/304 - Sels inorganiques, minéraux, oligo-éléments
  • A23L 1/305 - Aminoacides, peptides ou protéines 
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
  • C07C 227/14 - Préparation de composés contenant des groupes amino et carboxyle liés au même squelette carboné à partir de composés contenant déjà des groupes amino et carboxyle ou leurs dérivés

18.

VIVA

      
Numéro d'application 105779200
Statut Enregistrée
Date de dépôt 2000-05-05
Date d'enregistrement 2004-05-11
Propriétaire Viva Pharmaceutical Inc. (Canada)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés

Produits et services

(1) Analgesics, tranquilizers, antihistamines, anti-histamines, antacids, antidiarrhoeal preparations, anticoagulants, anti-hypertension preparations, anti-diabetic agents, diuretics, vitamins and minerals. (2) Marine oils extracts, vegetable oil extracts, enzymes, amino acids, hormones, immunoglobin products, anti-oxidants, natural antibiotics.

19.

PLANT EXTRACT COMPOSITIONS FOR THE TREATMENT OF INFLUENZA AND INFLAMMATION

      
Numéro de document 02754064
Statut Délivré - en vigueur
Date de dépôt 2010-03-02
Date d'octroi 2017-06-20
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Jason Jiang-Chung

Abrégé


A composition for affecting one or more of influenza, inflammation, and immune
system function, said composi-tion
comprising an extract prepared from Radix isatidis and an extract prepared
from Flos Lonicerae. In alternative embodiments,
the composition further comprises one or more of an extract prepared from
Poria cocos(Schw.) Wolf and an extract prepared from
Herba houttuyniae. Method for treating one or more of influenza, inflammation
by administering a patient a therapeutically effective
amount of the above composition.

Classes IPC  ?

  • A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
  • A61K 36/076 - Poria
  • A61K 36/315 - Isatis, p. ex. indigo
  • A61K 36/355 - Lonicera (chèvrefeuille)
  • A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
  • A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
  • A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques

20.

N-ACETYL L-CYSTEINE CHELATES AND METHODS FOR MAKING AND USING THE SAME

      
Numéro de document 02922396
Statut Délivré - en vigueur
Date de dépôt 2013-08-02
Date d'octroi 2017-01-10
Propriétaire VIVA PHARMACEUTICAL, INC. (Canada)
Inventeur(s)
  • Daniels, Rhett Sean
  • Xie, Xueju

Abrégé

A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stirring and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.

Classes IPC  ?

  • A23L 33/165 - Complexes ou chélates
  • A23L 33/175 - Acides aminés
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 33/04 - Soufre, sélénium ou tellureLeurs composés
  • A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
  • A61K 33/24 - Métaux lourdsLeurs composés
  • A61K 33/30 - ZincSes composés
  • A61K 33/32 - ManganèseSes composés
  • A61K 33/34 - CuivreSes composés
  • A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
  • C07C 323/59 - Thiols, sulfures, hydropolysulfures ou polysulfures substitués par des halogènes, des atomes d'oxygène ou d'azote ou par des atomes de soufre ne faisant pas partie de groupes thio contenant des groupes thio et des groupes carboxyle liés au même squelette carboné ayant les atomes de soufre des groupes thio liés à des atomes de carbone acycliques du squelette carboné le squelette carboné étant substitué de plus par des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso avec des groupes amino liés au squelette carboné avec des groupes amino acylés liés au squelette carboné

21.

CHEWABLE SOFTGEL CAPSULES

      
Numéro de document 02707882
Statut Délivré - en vigueur
Date de dépôt 2010-04-27
Date d'octroi 2012-04-03
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Yu-Lung
  • Ko, Chien-Kuang
  • Ko, Jason Jiang-Chung

Abrégé


A chewable softgel capsule configured for encasing orally ingestible articles.
The
chewable soft capsule is provided with an outer shell composition which
comprises at least one
gelatin in a range of 20% to 60% of the total weight of the shell composition
and more
preferably between about 30% to 47%, at least one plasticizer in an amount
selected to render
flexible the outer shell composition, at least one starch, and an anti-tacking
and softening agent
in an amount selected to render the outer shell composition non-sticky, and
water. In one
embodiment the chewable soft capsule comprises the at least one starch in a
range of about 5%
to 30% of the total weight and more preferably about 10% to 20% of the total
weight of the shell
composition. The chewable softgel capsule is suitable for encapsulating
medicines,
pharmaceutical compositions, nutraceuticals, vitamins, nutritional
supplements, and the like.

Classes IPC  ?

  • A61J 3/00 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat

22.

PROBIOTIC SOFT GEL COMPOSITIONS

      
Numéro de document 02816538
Statut Délivré - en vigueur
Date de dépôt 2011-11-01
Date d'octroi 2017-10-24
Propriétaire VIVA PHARMACEUTICAL INC. (Canada)
Inventeur(s)
  • Xie, Xueju
  • Ko, Jason

Abrégé

This disclosure relates to soft gel capsules. In particular, this disclosure relates to soft gel capsules comprising soft gel capsule comprising an outer shell comprising gelatin; and a filling comprising a probiotic and a desiccant. This disclosure further relates a process for producing a soft gel capsule, said process comprising providing an outer shell composition comprising a gelling agent; providing a filling composition comprising a probiotic and a desiccant; forming a soft gel capsule from the outer shell composition; and introducing the filling composition to the inside of the outer shell composition.

Classes IPC  ?

  • A61J 3/07 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de capsules ou de petits conteneurs similaires à absorber par voie buccale
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61K 35/741 - Probiotiques
  • A61K 35/745 - Bifidobactéries
  • A61P 3/12 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase des électrolytes